Statins for the prevention of stroke: A meta-analysis of randomized controlled trials

PLoS ONE

Volumn 9, Issue 3, 2014, Pages

  Wang, Wen ^a   Zhang, Bo ^a  

^a DALIAN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PLACEBO;

ARTICLE; BRAIN HEMORRHAGE; CEREBROVASCULAR ACCIDENT; DRUG EFFICACY; HEMODIALYSIS; HUMAN; INCIDENCE; KIDNEY TRANSPLANTATION; META ANALYSIS; PREVENTION STUDY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK REDUCTION; SYSTEMATIC REVIEW; MORTALITY; PRIMARY PREVENTION; RISK; STROKE;

HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; INCIDENCE; PRIMARY PREVENTION; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK; STROKE;

EID: 84898648943     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0092388     Document Type: Article

References (35)

1. Mohr JP, Albers GW, Amarenco P, Babikian VL, Biller J, et al. (1997) American Heart Association Prevention Conference. IV. Prevention and Rehabilitation of Stroke. Etiology of stroke. Stroke 28: 1501-1506.
2. Kent DM (2006) Stroke-an equal opportunity for the initiation of statin (Pubitemid 44200655)
3. Robinson JG, Smith B, Maheshwari N, Schrott H (2005) Pleiotropic effects of statins: benefit beyond cholesterol reduction? A meta-regression analysis. J Am Coll Cardiol 46: 1855-1862. (Pubitemid 41579807)
4. Calabro P, Yeh ET (2005) The pleiotropic effects of statins. Curr Opin Cardiol 20: 541-546. (Pubitemid 41565340)
5. Chen J, Zhang ZG, Li Y, Wang Y, Wang L, et al. (2003) Statins induce angiogenesis, neurogenesis, and synaptogenesis after stroke. Ann Neurol 53: 743-751. (Pubitemid 36622511)
6. Grundy SM (1997) Cholesterol and coronary heart disease. The 21st century. Arch Intern Med 157: 1177-1184. (Pubitemid 27251644)
7. (1994) Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 344: 1383-1389.
8. (1998) Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group. N Engl J Med 339: 1349-1357.
9. Heart Protection Study Collaborative G (2002) MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20, 536 high-risk individuals: a randomised placebo-controlled trial. Lancet 360: 7-22.
10. Athyros VG, Papageorgiou AA, Mercouris BR, Athyrou VV, Symeonidis AN, et al. (2002) Treatment with atorvastatin to the National Cholesterol Educational Program goal versus 'usual' care in secondary coronary heart disease prevention. The GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) study. Curr Med Res Opin 18: 220-228.
11. Koren MJ, Hunninghake DB, Investigators A (2004) Clinical outcomes in managed-care patients with coronary heart disease treated aggressively in lipid-lowering disease management clinics: the alliance study. J Am Coll Cardiol 44: 1772-1779. (Pubitemid 39424074)
12. Knopp RH, d'Emden M, Smilde JG, Pocock SJ (2006) Efficacy and safety of atorvastatin in the prevention of cardiovascular end points in subjects with type 2 diabetes: the Atorvastatin Study for Prevention of Coronary Heart Disease Endpoints in non-insulin-dependent diabetes mellitus (ASPEN). Diabetes Care 29: 1478-1485. (Pubitemid 44127567)
13. Sever PS, Poulter NR, Dahlof B, Wedel H, Beevers G, et al. (2008) The Anglo-Scandinavian Cardiac Outcomes Trial lipid lowering arm: extended observations 2 years after trial closure. Eur Heart J 29: 499-508. (Pubitemid 351264177)
14. White HD, Simes RJ, Anderson NE, Hankey GJ, Watson JD, et al. (2000) Pravastatin therapy and the risk of stroke. N Engl J Med 343: 317-326. (Pubitemid 30616697)
15. Nakamura H, Arakawa K, Itakura H, Kitabatake A, Goto Y, et al. (2006) Primary prevention of cardiovascular disease with pravastatin in Japan (MEGA Study): a prospective randomised controlled trial. Lancet 368: 1155-1163. (Pubitemid 44444932)
16. Officers A, Coordinators for the ACRGTA, Lipid-Lowering Treatment to Prevent Heart Attack T (2002) Major outcomes in moderately hypercholester-olemic, hypertensive patients randomized to pravastatin vs usual care: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT). JAMA 288: 2998-3007.
17. Shepherd J, Blauw GJ, Murphy MB, Bollen EL, Buckley BM, et al. (2002) Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial. Lancet 360: 1623-1630. (Pubitemid 35379733)
18. Hitman GA, Colhoun H, Newman C, Szarek M, Betteridge DJ, et al. (2007) Stroke prediction and stroke prevention with atorvastatin in the Collaborative Atorvastatin Diabetes Study (CARDS). Diabet Med 24: 1313-1321. (Pubitemid 350179426)
19. Amarenco P, Bogousslavsky J, Callahan A, 3rd, Goldstein LB, Hennerici M, et al. (2006) High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med 355: 549-559. (Pubitemid 44202151)
20. Plehn JF, Davis BR, Sacks FM, Rouleau JL, Pfeffer MA, et al. (1999) Reduction of stroke incidence after myocardial infarction with pravastatin: the Cholesterol and Recurrent Events (CARE) study. The Care Investigators. Circulation 99: 216-223. (Pubitemid 29056362)
21. Heart Protection Study Collaborative G (2002) MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20, 536 high-risk individuals: a randomised placebo-controlled trial. Lancet 360: 7-22.
22. Waters DD, Schwartz GG, Olsson AG, Zeiher A, Oliver MF, et al. (2002) Effects of atorvastatin on stroke in patients with unstable angina or non-Q-wave myocardial infarction: a Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) substudy. Circulation 106: 1690-1695.
23. Kjekshus J, Apetrei E, Barrios V, Bohm M, Cleland JG, et al. (2007) Rosuvastatin in older patients with systolic heart failure. N Engl J Med 357: 2248-2261. (Pubitemid 350190755)
24. Everett BM, Glynn RJ, MacFadyen JG, Ridker PM (2010) Rosuvastatin in the prevention of stroke among men and women with elevated levels of C-reactive protein: justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER). Circulation 121: 143-150.
25. Wanner C, Krane V, Marz W, Olschewski M, Mann JF, et al. (2005) Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis. N Engl J Med 353: 238-248. (Pubitemid 41058323)
26. Fellstrom BC, Jardine AG, Schmieder RE, Holdaas H, Bannister K, et al. (2009) Rosuvastatin and cardiovascular events in patients undergoing hemodialysis. N Engl J Med 360: 1395-1407.
27. Abedini S, Holme I, Fellstrom B, Jardine A, Cole E, et al. (2009) Cerebrovascular events in renal transplant recipients. Transplantation 87: 112-117.
28. Vaughan CJ, Delanty N (1999) Neuroprotective properties of statins in cerebral ischemia and stroke. Stroke 30: 1969-1973. (Pubitemid 29411843)
29. Moonis M, Kane K, Schwiderski U, Sandage BW, Fisher M (2005) HMG-CoA reductase inhibitors improve acute ischemic stroke outcome. Stroke 36: 1298-1300. (Pubitemid 40798758)
30. Amarenco P, Lavallee P, Touboul PJ (2004) Stroke prevention, blood cholesterol, and statins. Lancet Neurol 3: 271-278. (Pubitemid 38510197)
31. Willey JZ, Elkind MS (2010) 3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors in the treatment of central nervous system diseases. Arch Neurol 67: 1062-1067.
32. Rysz J, Aronow WS, Stolarek RS, Hannam S, Mikhailidis DP, et al. (2009) Nephroprotective and clinical potential of statins in dialyzed patients. Expert Opin Ther Targets 13: 541-550.
33. Baigent C, Keech A, Kearney PM, Blackwell L, Buck G, et al. (2005) Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90, 056 participants in 14 randomised trials of statins. Lancet 366: 1267-1278.
34. Lakhan SE, Bagchi S, Hofer M (2010) Statins and clinical outcome of acute ischemic stroke: a systematic review. Int Arch Med 3: 22.
35. Goldstein LB, Amarenco P, Szarek M, Callahan A, 3rd, Hennerici M, et al. (2008) Hemorrhagic stroke in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels study. Neurology 70: 2364-2370.